Skip to main content
Article
High-Resolution Peripheral Quantitative Computed Tomography and Finite Element Analysis of Bone Strength at the Distal Radius in Ovariectomized Adult Rhesus Monkey Demonstrate Efficacy of Odanacatib and Differentiation from Alendronate
Bone
  • Antonio Cabal
  • Richa Y. Jayakar
  • Swanand Sardesai
  • Eual A. Phillips
  • John Szumiloski
  • Diane J. Posavec
  • Parker D. Mathers
  • Alan T. Savitz
  • Boyd B. Scott
  • Christopher T. Winkelmann
  • Sherri Motzel
  • Lynn Cook
  • Richard Hargreaves
  • Jeffrey L. Evelhoch
  • Bernard J. Dardzinski
  • Thomas N. Hangartner, Wright State University - Main Campus
  • Paul J. McCracken
  • Le T. Duong
  • Donald S. Williams
Document Type
Article
Publication Date
10-1-2013
Abstract
Translational evaluation of disease progression and treatment response is critical to the development of therapies for osteoporosis. In this study, longitudinal in-vivo monitoring of odanacatib (ODN) treatment efficacy was compared to alendronate (ALN) in ovariectomized (OVX) non-human primates (NHPs) using high-resolution peripheral computed tomography (HR-pQCT). Treatment effects were evaluated using several determinants of bone strength, density and quality, including volumetric bone mineral density (vBMD), three-dimensional structure, finite element analysis (FEA) estimated peak force and biomechanical properties at the ultradistal (UD) radius at baseline, 3, 6, 9, 12, and 18 months of dosing in three treatment groups: vehicle (VEH), low ODN (2 mg/kg/day, L-ODN), and ALN (30 μg/kg/week). Biomechanical axial compression tests were performed at the end of the study. Bone strength estimates using FEA were validated by ex-vivo mechanical compression testing experiments. After 18 months of dosing, L-ODN demonstrated significant increases from baseline in integral vBMD (13.5%), cortical thickness (24.4%), total bone volume fraction BV/TV (13.5%), FEA-estimated peak force (26.6%) and peak stress (17.1%), respectively. Increases from baseline for L-ODN at 18 months were significantly higher than that for ALN in DXA-based aBMD (7.6%), cortical thickness (22.9%), integral vBMD (12.2%), total BV/TV (10.1%), FEA peak force (17.7%) and FEA peak stress (11.5%), respectively. These results demonstrate a superior efficacy of ODN treatment compared to ALN at the UD radii in ovariectomized NHPs.
DOI
10.1016/j.bone.2013.06.011
Citation Information
Antonio Cabal, Richa Y. Jayakar, Swanand Sardesai, Eual A. Phillips, et al.. "High-Resolution Peripheral Quantitative Computed Tomography and Finite Element Analysis of Bone Strength at the Distal Radius in Ovariectomized Adult Rhesus Monkey Demonstrate Efficacy of Odanacatib and Differentiation from Alendronate" Bone Vol. 56 Iss. 2 (2013) p. 497 - 505 ISSN: 87563282
Available at: http://works.bepress.com/thomas_hangartner/124/